高通量测序技术在遗传性耳聋研究中的应用及研究进展

doi:10.16288/j.yczz.16-376

遗传 ›› 2017, Vol. 39 ›› Issue (3): 208-219.doi: 10.16288/j.yczz.16-376

高通量测序技术在遗传性耳聋研究中的应用及研究进展

王翠翠(),袁慧军()

第三军医大学第一附属医院医学遗传中心,重庆400038

收稿日期:2016-11-07 修回日期:2017-01-11 出版日期:2017-03-20 发布日期:2017-02-10
作者简介:王翠翠,博士,研究方向：遗传性耳聋的相关研究。E-mail: cuicuiwang_169@163.com|袁慧军，博士，教授，研究方向：聋病分子遗传学。E-mail: yuanhj301@163.com
基金资助:
国家自然科学基金项目(81530031)

Application and progress of high-throughput sequencing technologies in the research of hereditary hearing loss

Wang Cuicui(),Yuan Huijun()

Medical Genetics Center, First Affiliated Hospital of the Third Military University, Chongqing 400038, China

Received:2016-11-07 Revised:2017-01-11 Online:2017-03-20 Published:2017-02-10
Supported by:
the Natural Science Foundation of China(81530031)

摘要/Abstract

摘要：

耳聋是一种常见的严重出生缺陷,阐明遗传性耳聋的致病机理不仅能够在临床上辅助诊断,为遗传咨询及耳聋预防提供依据,而且能促进人们更深入地了解耳聋的致病机制,开发新的治疗方法。随着基因组研究技术不断创新,以全基因组测序、全外显子组测序、目标区域测序为代表的高通量测序技术在遗传性耳聋研究中已得到广泛应用。本文总结了近5年全外显子组测序和目标区域测序在遗传性耳聋致病基因研究及临床分子诊断中应用及研究进展,希望能够有助于我国临床耳聋基因诊断技术的发展及诊断水平的提升。

关键词: 遗传性耳聋, 致病基因, 全外显子组测序, 目标区域测序

Abstract:

Hearing loss (HL) is the most common birth defect. Elucidating the genetic basis of hereditary deafness can not only assist diagnosis, provide the basis for genetic counseling and the prevention of deafness, but also bring a deeper understanding of the disease pathogenesis. In the genomic era, high-throughput sequencing technologies, represented by whole genome sequencing (WGS), whole exome sequencing (WES) or target region sequencing, have been widely used in the studies of hereditary HL. Here, we summarize the application and progress of WES and target region sequencing in the research of causative genes and clinical molecular diagnosis of hereditary HL, hoping to be helpful for the development and improvement of clinical genetic diagnosis of deafness in China.

Key words: hereditary hearing loss, causative genes, whole exome sequencing, target region sequencing

王翠翠,袁慧军. 高通量测序技术在遗传性耳聋研究中的应用及研究进展[J]. 遗传, 2017, 39(3): 208-219.

Wang Cuicui,Yuan Huijun. Application and progress of high-throughput sequencing technologies in the research of hereditary hearing loss[J]. Hereditas(Beijing), 2017, 39(3): 208-219.

参考文献

[1]	Margulies M, Egholm M, Altman WE, Attiya S, Bader JS, Bemben LA, Berka J, Braverman MS, Chen YJ, Chen ZT, Dewell SB, Du L, Fierro JM, Gomes XV, Godwin BC, He W, Helgesen S, Ho CH, Irzyk GP, Jando SC, Alenquer MLI, Jarvie TP, Jirage KB, Kim JB, Knight JR, Lanza JR, Leamon JH, Lefkowitz SM, Lei M, Li J, Lohman KL, Lu H, Makhijani VB, McDade KE, McKenna MP, Myers EW, Nickerson E, Nobile JR, Plant R, Puc BP, Ronan MT, Roth GT, Sarkis GJ, Simons JF, Simpson JW, Srinivasan M, Tartaro KR, Tomasz A, Vogt KA, Volkmer GA, Wang SH, Wang Y, Weiner MP, Yu PG, Begley RF, Rothberg JM. Genome sequencing in microfabricated high-density picolitre reactors. Nature, 2005, 437(7057): 376-380.
[2]	Wheeler DA, Srinivasan M, Egholm M, Shen YF, Chen L, McGuire A, He W, Chen YJ, Makhijani V, Roth GT, Gomes X, Tartaro K, Niazi F, Turcotte CL, Irzyk GP, Lupski JR, Chinault C, Song XZ, Liu Y, Yuan Y, Nazareth L, Qin X, Muzny DM, Margulies M, Weinstock GM, Gibbs RA, Rothberg JM. The complete genome of an individual by massively parallel DNA sequencing. Nature, 2008, 452(7189): 872-876.
[3]	Vele O, Schrijver I. Inherited hearing loss: molecular genetics and diagnostic testing. Expert Opin Med Diagn, 2008, 2(3): 231-248.
[4]	de Kok YJ, van der Maarel SM, Bitner-Glindzicz M, Huber I, Monaco AP, Malcolm S, Pembrey ME, Ropers HH, Cremers FP. Association between X-linked mixed deafness and mutations in the POU domain gene POU3F4. Science, 1995, 267(5198): 685-688.
[5]	Diaz-Horta O, Duman D, Foster II J, Sirmaci A, Gonzalez M, Mahdieh N, Fotouhi N, Bonyadi M, Cengiz FB, Menendez I, Ulloa RH, Edwards YJK, Züchner S, Blanton S, Tekin M. Whole-exome sequencing efficiently detects rare mutations in autosomal recessive nonsyndromic hearing loss. PLoS One, 2012, 7(11): e50628.
[6]	Shearer AE, DeLuca AP, Hildebrand MS, Taylor KR, Gurrola II J, Scherer S, Scheetz TE, Smith RJH. Comprehensive genetic testing for hereditary hearing loss using massively parallel sequencing. Proc Natl Acad Sci USA, 2010, 107(49): 21104-21109.
[7]	Sivakumaran TA, Husami A, Kissell D, Zhang WY, Keddache M, Black AP, Tinkle BT, Greinwald JH, Jr., Zhang KJ. Performance evaluation of the next-generation sequencing approach for molecular diagnosis of hereditary hearing loss. Otolaryngol Head Neck Surg, 2013, 148(6): 1007-1016.
[8]	Brownstein Z, Friedman LM, Shahin H, Oron-Karni V, Kol N, Rayyan AA, Parzefall T, Lev D, Shalev S, Frydman M, Davidov B, Shohat M, Rahile M, Lieberman S, Levy-Lahad E, Lee MK, Shomron N, King MC, Walsh T, Kanaan M, Avraham KB. Targeted genomic capture and massively parallel sequencing to identify genes for hereditary hearing loss in Middle Eastern families. Genome Biol, 2011, 12(9): R89.
[9]	Nishio SY, Usami S. Deafness gene variations in a 1120 nonsyndromic hearing loss cohort: molecular epidemiology and deafness mutation spectrum of patients in Japan. Ann Otol Rhinol Laryngol, 2015, 124(Suppl. 1): 49S-60S.
[10]	Sloan-Heggen CM, Bierer AO, Shearer AE, Kolbe DL, Nishimura CJ, Frees KL, Ephraim SS, Shibata SB, Booth KT, Campbell CA, Ranum PT, Weaver AE, Black-Ziegelbein EA, Wang DH, Azaiez H, Smith RJH. Comprehensive genetic testing in the clinical evaluation of 1119 patients with hearing loss. Hum Genet, 2016, 135(4): 441-450.
[11]	Baek JI, Oh SK, Kim DB, Choi SY, Kim UK, Lee KY, Lee SH. Targeted massive parallel sequencing: the effective detection of novel causative mutations associated with hearing loss in small families. Orphanet J Rare Dis, 2012, 7: 60.
[12]	Eppsteiner RW, Shearer AE, Hildebrand MS, Deluca AP, Ji HH, Dunn CC, Black-Ziegelbein EA, Casavant TL, Braun TA, Scheetz TE, Scherer SE, Hansen MR, Gantz BJ, Smith RJH. Prediction of cochlear implant performance by genetic mutation: the spiral ganglion hypothesis. Hear Res, 2012, 292(1-2): 51-58.
[13]	Choi BY, Park G, Gim J, Kim AR, Kim BJ, Kim HS, Park JH, Park T, Oh SH, Han KH, Park WY. Diagnostic application of targeted resequencing for familial nonsyndromic hearing loss. PLoS One, 2013, 8(8): e68692.
[14]	Mutai H, Suzuki N, Shimizu A, Torii C, Namba K, Morimoto N, Kudoh J, Kaga K, Kosaki K, Matsunaga T. Diverse spectrum of rare deafness genes underlies early-childhood hearing loss in Japanese patients: a cross- sectional, multi-center next-generation sequencing study. Orphanet J Rare Dis, 2013, 8: 172.
[15]	Shearer AE, Black-Ziegelbein EA, Hildebrand MS, Eppsteiner RW, Ravi H, Joshi S, Guiffre AC, Sloan CM, Happe S, Howard SD, Novak B, Deluca AP, Taylor KR, Scheetz TE, Braun TA, Casavant TL, Kimberling WJ, Leproust EM, Smith RJH. Advancing genetic testing for deafness with genomic technology. J Med Genet, 2013, 50(9): 627-634.
[16]	Wu CC, Lin YH, Lu YC, Chen PJ, Yang WS, Hsu CJ, Chen PL. Application of massively parallel sequencing to genetic diagnosis in multiplex families with idiopathic sensorineural hearing impairment. PLoS One, 2013, 8(2): e57369.
[17]	Yang T, Wei XM, Chai YC, Li L, Wu H. Genetic etiology study of the non-syndromic deafness in Chinese Hans by targeted next-generation sequencing. Orphanet J Rare Dis, 2013, 8: 85.
[18]	Gu X, Guo L, Ji H, Sun S, Chai R, Wang L, Li H. Genetic testing for sporadic hearing loss using targeted massively parallel sequencing identifies 10 novel mutations. Clin Genet, 2015, 87(6): 588-593.
[19]	Ji HT, Lu JQ, Wang JJ, Li HW, Lin X. Combined examination of sequence and copy number variations in human deafness genes improves diagnosis for cases of genetic deafness. BMC Ear Nose Throat Disord, 2014, 14: 9.
[20]	Park JH, Kim NKD, Kim AR, Rhee J, Oh SH, Koo JW, Nam JY, Park WY, Choi BY. Exploration of molecular genetic etiology for Korean cochlear implantees with severe to profound hearing loss and its implication. Orphanet J Rare Dis, 2014, 9: 167.
[21]	Vona B, Müller T, Nanda I, Neuner C, Hofrichter MAH, Schr?der J, Bartsch O, L??ig A, Keilmann A, Schraven S, Kraus F, Shehata-Dieler W, Haaf T. Targeted next-generation sequencing of deafness genes in hearing-impaired individuals uncovers informative mutations. Genet Med, 2014, 16(12): 945-953.
[22]	Wei QJ, Zhu HM, Qian XL, Chen ZB, Yao J, Lu YJ, Cao X, Xing GQ. Targeted genomic capture and massively parallel sequencing to identify novel variants causing Chinese hereditary hearing loss. J Transl Med, 2014, 12: 311.
[23]	Kim BJ, Kim AR, Park G, Park WY, Chang SO, Oh SH, Choi BY. Targeted exome sequencing of deafness genes after failure of auditory phenotype-driven candidate gene screening. Otol Neurotol, 2015, 36(6): 1096-1102.
[24]	Atik T, Onay H, Aykut A, Bademci G, Kirazli T, Tekin M, Ozkinay F. Comprehensive analysis of deafness genes in families with autosomal recessive nonsyndromic hearing loss. PLoS One, 2015, 10(11): e0142154.
[25]	Sloan-Heggen CM, Babanejad M, Beheshtian M, Simpson AC, Booth KT, Ardalani F, Frees KL, Mohseni M, Mozafari R, Mehrjoo Z, Jamali L, Vaziri S, Akhtarkhavari T, Bazazzadegan N, Nikzat N, Arzhangi S, Sabbagh F, Otukesh H, Seifati SM, Khodaei H, Taghdiri M, Meyer NC, Daneshi A, Farhadi M, Kahrizi K, Smith RJ, Azaiez H, Najmabadi H. Characterising the spectrum of autosomal recessive hereditary hearing loss in Iran. J Med Genet, 2015, 52(12): 823-829.
[26]	Chen Y, Wang ZT, Wang ZY, Chen DY, Chai YC, Pang XH, Sun LH, Wang XW, Yang T, Wu H. Targeted next-generation sequencing in Uyghur families with non-syndromic sensorineural hearing loss. PLoS One, 2015, 10(5): e0127879.
[27]	Tekin D, Yan D, Bademci G, Feng Y, Guo SR, Foster II J, Blanton S, Tekin M, Liu XZ. A next-generation sequencing gene panel (MiamiOtoGenes) for comprehensive analysis of deafness genes. Hear Res, 2016, 333: 179-184.
[28]	Bademci G, Foster II J, Mahdieh N, Bonyadi M, Duman D, Cengiz FB, Menendez I, Diaz-Horta O, Shirkavand A, Zeinali S, Subasioglu A, Tokgoz-Yilmaz S, Huesca-Hernandez F, de la Luz Arenas-Sordo M, Dominguez-Aburto J, Hernandez-Zamora E, Montenegro P, Paredes R, Moreta G, Vinueza R, Villegas F, Mendoza-Benitez S, Guo SR, Bozan N, Tos T, Incesulu A, Sennaroglu G, Blanton SH, Ozturkmen-Akay H, Yildirim-Baylan M, Tekin M. Comprehensive analysis via exome sequencing uncovers genetic etiology in autosomal recessive nonsyndromic deafness in a large multiethnic cohort. Genet Med, 2016, 18(4): 364-371.
[29]	Naz S, Imtiaz A, Mujtaba G, Maqsood A, Bashir R, Bukhari I, Khan MR, Ramzan M, Fatima A, Rehman AU, Iqbal M, Chaudhry T, Lund M, Brewer CC, Morell RJ, Friedman TB. Genetic causes of moderate to severe hearing loss point to modifiers. Clin Genet, 2016, doi: 10.1111/cge.12856.
[30]	Sommen M, Schrauwen I, Vandeweyer G, Boeckx N, Corneveaux JJ, van den Ende J, Boudewyns A, De Leenheer E, Janssens S, Claes K, Verstreken M, Strenzke N, Pred?hl F, Wuyts W, Mortier G, Bitner-Glindzicz M, Moser T, Coucke P, Huentelman MJ, Van Camp G. DNA diagnostics of hereditary hearing loss: a targeted resequencing approach combined with a mutation classification system. Hum Mutat, 2016, 37(8): 812-819.
[31]	Hoppman N, Aypar U, Brodersen P, Brown N, Wilson J, Babovic-Vuksanovic D. Genetic testing for hearing loss in the United States should include deletion/duplication analysis for the deafness/infertility locus at 15q15.3. Mol Cytogenet, 2013, 6(1): 19.
[32]	Shearer AE, Smith RJ. Massively parallel sequencing for genetic diagnosis of hearing loss: the new standard of care. Otolaryngol Head Neck Surg, 2015, 153(2): 175-182.
[33]	Kimberling WJ, Hildebrand MS, Shearer AE, Jensen ML, Halder JA, Trzupek K, Cohn ES, Weleber RG, Stone EM, Smith RJH. Frequency of Usher syndrome in two pediatric populations: implications for genetic screening of deaf and hard of hearing children. Genet Med, 2010, 12(8): 512-516.
[34]	Wang CC, Lu Y, Cheng J, Zhang L, Liu W, Peng WH, Zhang D, Duan H, Han DY, Yuan HJ. Identification of KCNQ1 compound heterozygous mutations in three Chinese families with Jervell and Lange-Nielsen syndrome. Acta Otolaryngol, 2016, doi: 10.1080/00016489.2016. 1260156.
[35]	Shearer AE, Eppsteiner RW, Booth KT, Ephraim SS, Gurrola II J, Simpson A, Black-Ziegelbein EA, Joshi S, Ravi H, Giuffre AC, Happe S, Hildebrand MS, Azaiez H, Bayazit YA, Erdal ME, Lopez-Escamez JA, Gazquez I, Tamayo ML, Gelvez NY, Leal GL, Jalas C, Ekstein J, Yang T, Usami SI, Kahrizi K, Bazazzadegan N, Najmabadi H, Scheetz TE, Braun TA, Casavant TL, LeProust EM, Smith RJ. Utilizing ethnic-specific differences in minor allele frequency to recategorize reported pathogenic deafness variants. Am J Hum Genet, 2014, 95(4): 445-453.
[36]	Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR. A method and server for predicting damaging missense mutations. Nat Methods, 2010, 7(4): 248-249.
[37]	Thevenon J, Duffourd Y, Masurel-Paulet A, Lefebvre M, Feillet F, El Chehadeh-Djebbar S, St-Onge J, Steinmetz A, Huet F, Chouchane M, Darmency-Stamboul V, Callier P, Thauvin-Robinet C, Faivre L, Rivière JB. Diagnostic odyssey in severe neurodevelopmental disorders: toward clinical whole-exome sequencing as a first-line diagnostic test. Clin Genet, 2016, 89(6): 700-707.
[38]	Jacob HJ, Abrams K, Bick DP, Brodie K, Dimmock DP, Farrell M, Geurts J, Harris J, Helbling D, Joers BJ, Kliegman R, Kowalski G, Lazar J, Margolis DA, North P, Northup J, Roquemore-Goins A, Scharer G, Shimoyama M, Strong K, Taylor B, Tsaih SW, Tschannen MR, Veith RL, Wendt-Andrae J, Wilk B, Worthey EA. Genomics in clinical practice: lessons from the front lines.. Sci Transl Med, 2013, 5(194): 194cm5.
[39]	Bademci G, Cengiz FB, Foster II J, Duman D, Sennaroglu L, Diaz-Horta O, Atik T, Kirazli T, Olgun L, Alper H, Menendez I, Loclar I, Sennaroglu G, Tokgoz-Yilmaz S, Guo S, Olgun Y, Mahdieh N, Bonyadi M, Bozan N, Ayral A, Ozkinay F, Yildirim-Baylan M, Blanton SH, Tekin M. Variations in multiple syndromic deafness genes mimic non-syndromic hearing loss. Sci Rep, 2016, 6: 31622.
[40]	Lander ES, Botstein D. Homozygosity mapping: a way to map human recessive traits with the DNA of inbred children. Science, 1987, 236(4808): 1567-1570.
[41]	Zheng J, Miller KK, Yang T, Hildebrand MS, Shearer AE, DeLuca AP, Scheetz TE, Drummond J, Scherer SE, Legan PK, Goodyear RJ, Richardson GP, Cheatham MA, Smith RJ, Dallos P. Carcinoembryonic antigen-related cell adhesion molecule 16 interacts with α-tectorin and is mutated in autosomal dominant hearing loss (DFNA4). Proc Natl Acad Sci USA, 2011, 108(10): 4218-4223.
[42]	Walsh T, Shahin H, Elkan-Miller T, Lee MK, Thornton AM, Roeb W, Rayyan AA, Loulus S, Avraham KB, King MC, Kanaan M. Whole exome sequencing and homozygosity mapping identify mutation in the cell polarity protein GPSM2 as the cause of nonsyndromic hearing loss DFNB82. Am J Hum Genet, 2010, 87(1): 90-94.
[43]	Zhang LP, Hu LX, Chai YC, Pang XH, Yang T, Wu H. A dominant mutation in the stereocilia-expressing gene TBC1D24 is a probable cause for nonsyndromic hearing impairment. Hum Mutat, 2014, 35(7): 814-818.
[44]	Rost S, Bach E, Neuner C, Nanda I, Dysek S, Bittner RE, Keller A, Bartsch O, Mlynski R, Haaf T, Müller CR, Kunstmann E. Novel form of X-linked nonsyndromic hearing loss with cochlear malformation caused by a mutation in the type IV collagen gene COL4A6. Eur J Hum Genet, 2014, 22(2): 208-215.
[45]	Delmaghani S, Aghaie A, Michalski N, Bonnet C, Weil D, Petit C. Defect in the gene encoding the EAR/EPTP domain-containing protein TSPEAR causes DFNB98 profound deafness. Hum Mol Genet, 2012, 21(17): 3835-3844.
[46]	Yariz KO, Duman D, Seco CZ, Dallman J, Huang MQ, Peters TA, Sirmaci A, Lu N, Schraders M, Skromne I, Oostrik J, Diaz-Horta O, Young JI, Tokgoz-Yilmaz S, Konukseven O, Shahin H, Hetterschijt L, Kanaan M, Oonk AMM, Edwards YJK, Li HW, Atalay S, Blanton S, DeSmidt AA, Liu XZ, Pennings RJE, Lu ZM, Chen ZY, Kremer H, Tekin M. Mutations in OTOGL, encoding the inner ear protein otogelin-like, cause moderate sensorineural hearing loss. Am J Hum Genet, 2012, 91(5): 872-882.
[47]	Santos-Cortez RL, Lee K, Azeem Z, Antonellis PJ, Pollock LM, Khan S, Irfanullah, Andrade-Elizondo PB, Chiu I, Adams MD, Basit S, Smith JD, University of Washington Center for Mendelian Genomics, Nickerson DA, McDermott BM Jr, Ahmad W, Leal SM. Mutations in KARS, encoding lysyl-tRNA synthetase, cause autosomal-recessive nonsyndromic hearing impairment DFNB89. Am J Hum Genet, 2013, 93(1): 132-140.
[48]	Jaworek TJ, Richard EM, Ivanova AA, Giese APJ, Choo DI, Khan SN, Riazuddin S, Kahn RA, Riazuddin S. An alteration in ELMOD3, an Arl2 GTPase-activating protein, is associated with hearing impairment in humans. PLoS Genet, 2013, 9(9): e1003774.
[49]	Girotto G, Abdulhadi K, Buniello A, Vozzi D, Licastro D, d'Eustacchio A, Vuckovic D, Alkowari MK, Steel KP, Badii R, Gasparini P. Linkage study and exome sequencing identify a BDP1 mutation associated with hereditary hearing loss. PLoS One, 2013, 8(12): e80323.
[50]	Rehman AU, Santos-Cortez RLP, Morell RJ, Drummond MC, Ito T, Lee K, Khan AA, Basra MAR, Wasif N, Ayub M, Ali RA, Raza SI, University of Washington Center for Mendelian Genomics, Nickerson DA, Shendure J, Bamshad M, Riazuddin S, Billington N, Khan SN, Friedman PL, Griffith AJ, Ahmad W, Riazuddin S, Leal SM, Friedman TB. Mutations in TBC1D24, a gene associated with epilepsy, also cause nonsyndromic deafness DFNB86. Am J Hum Genet, 2014, 94(1): 144-152.
[51]	Santos-Cortez RL, Lee K, Giese AP, Ansar M, Amin-Ud- Din M, Rehn K, Wang X, Aziz A, Chiu I, Ali RH, Smith JD, University of Washington Center for Mendelian Genomics, Shendure J, Bamshad M, Nickerson DA, Ahmed ZM, Ahmad W, Riazuddin S, Leal SM. Adenylate cyclase 1 (ADCY1) mutations cause recessive hearing impairment in humans and defects in hair cell function and hearing in zebrafish. Hum Mol Genet, 2014, 23(12): 3289-3298.
[52]	Behlouli A, Bonnet C, Abdi S, Bouaita A, Lelli A, Hardelin JP, Schietroma C, Rous Y, Louha M, Cheknane A, Lebdi H, Boudjelida K, Makrelouf M, Zenati A, Petit C. EPS8, encoding an actin-binding protein of cochlear hair cell stereocilia, is a new causal gene for autosomal recessive profound deafness. Orphanet J Rare Dis, 2014, 9: 55.
[53]	Diaz-Horta O, Subasioglu-Uzak A, Grati M, DeSmidt A, Foster II J, Cao L, Bademci G, Tokgoz-Yilmaz S, Duman D, Cengiz FB, Abad C, Mittal R, Blanton S, Liu XZ, Farooq A, Walz K, Lu Z, Tekin M. FAM65B is a membrane-associated protein of hair cell stereocilia required for hearing. Proc Natl Acad Sci USA, 2014, 111(27): 9864-9868.
[54]	Li JX, Zhao XH, Xin Q, Shan S, Jiang BC, Jin YC, Yuan HJ, Dai P, Xiao R, Zhang QY, Xiao JJ, Shao CS, Gong YQ, Liu QJ. Whole-exome sequencing identifies a variant in TMEM132E causing autosomal-recessive nonsyndromic hearing loss DFNB99. Hum Mutat, 2015, 36(1): 98-105.
[55]	Imtiaz A, Kohrman DC, Naz S. A frameshift mutation in GRXCR2 causes recessively inherited hearing loss. Hum Mutat, 2014, 35(5): 618-624.
[56]	Dahmani M, Ammar-Khodja F, Bonnet C, Lefèvre GM, Hardelin JP, Ibrahim H, Mallek Z, Petit C. EPS8L2 is a new causal gene for childhood onset autosomal recessive progressive hearing loss. Orphanet J Rare Dis, 2015, 10: 96.
[57]	Mujtaba G, Schultz JM, Imtiaz A, Morell RJ, Friedman TB, Naz S. A mutation of MET, encoding hepatocyte growth factor receptor, is associated with human DFNB97 hearing loss. J Med Genet, 2015, 52(8): 548-552.
[58]	Santos-Cortez RL, Faridi R, Rehman AU, Lee K, Ansar M, Wang X, Morell RJ, Isaacson R, Belyantseva IA, Dai H, Acharya A, Qaiser TA, Muhammad D, Ali RA, Shams S, Hassan MJ, Shahzad S, Raza SI, Bashir ZEH, Smith JD, Nickerson DA, Bamshad MJ, University of Washington Center for Mendelian Genomics, Riazuddin S, Ahmad W, Friedman TB, Leal SM. Autosomal-recessive hearing impairment due to rare missense variants withinS1PR2. Am J Hum Genet, 2016, 98(2): 331-338.
[59]	Said MB, Grati M, Ishimoto T, Zou B, Chakchouk I, Ma Q, Yao Q, Hammami B, Yan D, Mittal R, Nakamichi N, Ghorbel A, Neng LL, Tekin M, Shi XR, Kato Y, Masmoudi S, Lu ZM, Hmani M, Liu XZ. A mutation in SLC22A4 encoding an organic cation transporter expressed in the cochlea strial endothelium causes human recessive non-syndromic hearing loss DFNB60. Hum Genet, 2016, 135(5): 513-524.
[60]	Zhao YL, Zhao FF, Zong L, Zhang P, Guan LP, Zhang JG, Wang DY, Wang J, Chai W, Lan L, Li Q, Han B, Yang L, Jin X, Yang WY, Hu XX, Wang XN, Li N, Li YR, Petit C, Wang J, Wang HY, Wang QJ. Exome sequencing and linkage analysis identified tenascin-C (TNC) as a novel causative gene in nonsyndromic hearing loss. PLoS One, 2013, 8(7): e69549.
[61]	Azaiez H, Booth KT, Bu FX, Huygen P, Shibata SB, Shearer AE, Kolbe D, Meyer N, Black-Ziegelbein EA, Smith RJH. TBC1D24 mutation causes autosomal-dominant nonsyndromic hearing loss. Hum Mutat, 2014, 35(7): 819-823.
[62]	Xing GQ, Yao J, Wu B, Liu TT, Wei QJ, Liu C, Lu YJ, Chen ZB, Zheng H, Yang XN, Cao X. Identification of OSBPL2 as a novel candidate gene for progressive nonsyndromic hearing loss by whole-exome sequencing. Genet Med, 2015, 17(3): 210-218.
[63]	Thoenes M, Zimmermann U, Ebermann I, Ptok M, Lewis MA, Thiele H, Morlot S, Hess MM, Gal A, Eisenberger T, Bergmann C, Nürnberg G, Nürnberg P, Steel KP, Knipper M, Bolz HJ. OSBPL2 encodes a protein of inner and outer hair cell stereocilia and is mutated in autosomal dominant hearing loss (DFNA67). Orphanet J Rare Dis, 2015, 10: 15.
[64]	Azaiez H, Decker AR, Booth KT, Simpson AC, Shearer AE, Huygen PLM, Bu FX, Hildebrand MS, Ranum PT, Shibata SB, Turner A, Zhang YZ, Kimberling WJ, Cornell RA, Smith RJH. HOMER2, a stereociliary scaffolding protein, is essential for normal hearing in humans and mice. PLoS Genet, 2015, 11(3): e1005137.
[65]	Gao JJ, Wang Q, Dong C, Chen SQ, Qi Y, Liu YH. Whole Exome sequencing identified MCM2 as a novel causative gene for autosomal dominant nonsyndromic deafness in a Chinese family. PLoS One, 2015, 10(7): e0133522.
[66]	Girotto G, Scheffer DI, Morgan A, Vozzi D, Rubinato E, Di Stazio M, Muzzi E, Pensiero S, Giersch AB, Corey DP, Gasparini P. PSIP1/LEDGF: a new gene likely involved in sensorineural progressive hearing loss. Sci Rep, 2015, 5: 18568.
[67]	Wang HH, Wang XW, He CF, Li HB, Qing J, Grati M, Hu ZM, Li JD, Hu YQ, Xia K, Mei LY, Wang XW, Yu JJ, Chen HS, Jiang L, Liu YL, Men MC, Zhang HL, Guan LP, Xiao JJ, Zhang JG, Liu XZ, Feng Y. Exome sequencing identifies a novel CEACAM16 mutation associated with autosomal dominant nonsyndromic hearing loss DFNA4B in a Chinese family. J Hum Genet, 2015, 60(3): 119-126.
[68]	Runge CL, Indap A, Zhou Y, Kent JW Jr, King E, Erbe CB, Cole R, Littrell J, Merath K, James R, Ruschendorf F, Kerschner JE, Marth G, Hubner N, Goring HH, Friedland DR, Kwok WM, Olivier M. Association of TMTC2 with human nonsyndromic sensorineural hearing loss. JAMA Otolaryngol Head Neck Surg, 2016, 142(9): 866-872.
[69]	Grati M, Yan D, Raval MH, Walsh T, Ma Q, Chakchouk I, Kannan-Sundhari A, Mittal R, Masmoudi S, Blanton SH, Tekin M, King MC, Yengo CM, Liu XZ. MYO3A Causes human dominant deafness and interacts with protocadherin 15-CD2 Isoform. Hum Mutat, 2016, 37(5): 481-487.
[70]	Requena T, Cabrera S, Martin-Sierra C, Price SD, Lysakowski A, Lopez-Escamez JA. Identification of two novel mutations in FAM136A and DTNA genes in autosomal-dominant familial Meniere's disease. Hum Mol Genet, 2015, 24(4): 1119-1126.
[71]	Ziff JL, Crompton M, Powell HR, Lavy JA, Aldren CP, Steel KP, Saeed SR, Dawson SJ. Mutations and altered expression of SERPINF1 in patients with familial otosclerosis. Hum Mol Genet, 2016, 25(12): 2393-2403.
[72]	Zong L, Guan J, Ealy M, Zhang QJ, Wang DY, Wang HY, Zhao YL, Shen ZR, Campbell CA, Wang FC, Yang J, Sun W, Lan L, Ding DL, Xie LY, Qi Y, Lou X, Huang XS, Shi Q, Chang SH, Xiong WP, Yin ZF, Yu N, Zhao H, Wang J, Wang J, Salvi RJ, Petit C, Smith RJ, Wang QJ. Mutations in apoptosis-inducing factor cause X-linked recessive auditory neuropathy spectrum disorder. J Med Genet, 2015, 52(8): 523-531.
[73]	Pierce SB, Walsh T, Chisholm KM, Lee MK, Thornton AM, Fiumara A, Opitz JM, Levy-Lahad E, Klevit RE, King MC. Mutations in the DBP-deficiency protein HSD17B4 cause ovarian dysgenesis, hearing loss, and ataxia of Perrault Syndrome. Am J Hum Genet, 2010, 87(2): 282-288.
[74]	Jenkinson EM, Rehman AU, Walsh T, Clayton-Smith J, Lee K, Morell RJ, Drummond MC, Khan SN, Naeem MA, Rauf B, Billington N, Schultz JM, Urquhart JE, Lee MK, Berry A, Hanley NA, Mehta S, Cilliers D, Clayton PE, Kingston H, Smith MJ, Warner TT, University of Washington Center for Mendelian Genomics, Black GC, Trump D, Davis JRE, Ahmad W, Leal SM, Riazuddin S, King MC, Friedman TB, Newman WG. Perrault syndrome is caused by recessive mutations in CLPP, encoding a mitochondrial ATP-dependent chambered protease. Am J Hum Genet, 2013, 92(4): 605-613.
[75]	Pierce SB, Gersak K, Michaelson-Cohen R, Walsh T, Lee MK, Malach D, Klevit RE, King MC, Levy-Lahad E. Mutations in LARS2, encoding mitochondrial leucyl-tRNA synthetase, lead to premature ovarian failure and hearing loss in Perrault syndrome. Am J Hum Genet, 2013, 92(4): 614-620.
[76]	Morino H, Pierce SB, Matsuda Y, Walsh T, Ohsawa R, Newby M, Hiraki-Kamon K, Kuramochi M, Lee MK, Klevit RE, Martin A, Maruyama H, King MC, Kawakami H. Mutations in Twinkle primase-helicase cause Perrault syndrome with neurologic features. Neurology, 2014, 83(22): 2054-2061.
[77]	Makrythanasis P, Temtamy S, Aglan MS, Otaify GA, Hamamy H, Antonarakis SE. A novel homozygous mutation in FGFR3 causes tall stature, severe lateral tibial deviation, scoliosis, hearing impairment, camptodactyly, and arachnodactyly. Hum Mutat, 2014, 35(8): 959-963.
[78]	Schwartzentruber J, Buhas D, Majewski J, Sasarman F, Papillon-Cavanagh S, Thiffaut I, Sheldon KM, Massicotte C, Patry L, Simon M, Zare AS, McKernan KJ, Consortium FC, Michaud J, Boles RG, Deal CL, Desilets V, Shoubridge EA, Samuels ME. Mutation in the nuclear-encoded mitochondrial isoleucyl-tRNA synthetase IARS2 in patients with cataracts, growth hormone deficiency with short stature, partial sensorineural deafness, and peripheral neuropathy or with Leigh syndrome. Hum Mutat, 2014, 35(11): 1285-1289.
[79]	Di Donato N, Neuhann T, Kahlert AK, Klink B, Hackmann K, Neuhann I, Novotna B, Schallner J, Krause C, Glass IA, Parnell SE, Benet-Pages A, Nissen AM, Berger W, Altmüller J, Thiele H, Weber BHF, Schrock E, Dobyns WB, Bier A, Rump A. Mutations in EXOSC2 are associated with a novel syndrome characterised by retinitis pigmentosa, progressive hearing loss, premature ageing, short stature, mild intellectual disability and distinctive gestalt. J Med Genet, 2016, 53(6): 419-425.
[80]	DeLuca AP, Weed MC, Haas CM, Halder JA, Stone EM. Apparent usher syndrome caused by the combination of BBS1-associated retinitis pigmentosa and SLC26A4-associated deafness. JAMA Ophthalmol, 2015, 133(8): 967-968.
[81]	Khateb S, Zelinger L, Mizrahi-Meissonnier L, Ayuso C, Koenekoop RK, Laxer U, Gross M, Banin E, Sharon D. A homozygous nonsense CEP250 mutation combined with a heterozygous nonsense C2orf71 mutation is associated with atypical Usher syndrome. J Med Genet, 2014, 51(7): 460-469.
[82]	Lu Y, Zhou XY, Jin ZG, Cheng J, Shen WD, Ji F, Liu LY, Zhang XG, Zhang M, Cao Y, Han DY, Choy K, Yuan HJ. Resolving the genetic heterogeneity of prelingual hearing loss within one family: performance comparison and application of two targeted next generation sequencing approaches. J Hum Genet, 2014, 59(11): 599-607.
[83]	Qing J, Yan D, Zhou Y, Liu Q, Wu WJ, Xiao ZA, Liu YY, Liu J, Du LL, Xie DH, Liu XZ. Whole-exome sequencing to decipher the genetic heterogeneity of hearing loss in a Chinese family with deaf by deaf mating. PLoS One, 2014, 9(10): e109178.

编辑推荐

Metrics

www.chinagene.cn
备案号：京ICP备09063187号
总访问:,今日访问:,当前在线:

高通量测序技术在遗传性耳聋研究中的应用及研究进展

Application and progress of high-throughput sequencing technologies in the research of hereditary hearing loss

RichHTML

PDF (PC)

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 9

编辑推荐

Metrics

[1]	姜义圣,许执恒. 脑发育疾病及发病机制[J]. 遗传, 2019, 41(9): 801-815.
[2]	杨应忠, 王亚平, 胥瑾, 格日力. 应用全外显子组测序筛查一高原肺水肿家系易感基因[J]. 遗传, 2017, 39(2): 135-142.
[3]	李元丰, 张红星, 张海涛, 彭晓波, 白丽丽, 贺福初, 邱泽武, 周钢桥. 一个中国遗传性血色病家系致病基因的突变分析[J]. 遗传, 2014, 36(11): 1152-1158.
[4]	邵谦之, 姜毅, 吴金雨. 全基因组测序及其在遗传性疾病研究及诊断中的应用[J]. 遗传, 2014, 36(11): 1087-1098.
[5]	何轶群许美芬于涵耿军伟施苏雪薛凌卢中秋管敏鑫. 血脂异常遗传性疾病的研究现状[J]. 遗传, 2013, 35(11): 1237-1243.
[6]	许飞，王慧君，马端. 表观遗传学——耳聋研究的新视野[J]. 遗传, 2012, 34(3): 253-259.
[7]	卜枫啸，彭聿，王树辉，潘琼，胡正茂，龚惠勇，张静，邬玲仟，梁德生，潘乾，冯永，夏昆，夏家辉，. 定位于5q31-5q32的DFNA52的20个候选基因的突变筛查[J]. 遗传, 2009, 31(1): 43-49.
[8]	陈静，杨淑芝，刘军，韩冰，王国建，张昕，康东洋，戴朴，杨伟炎，袁慧军. Waardenburg综合征Ⅱ型患者MITF基因突变分析[J]. 遗传, 2008, 30(4): 433-438.
[9]	王秋菊，杨伟炎，吴子明，郭维维，李庆忠，仇春燕. X连锁隐性遗传聋哑（deaf-mute）家系的遗传学特征分析[J]. 遗传, 2004, 26(5): 579-583.